Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Hachulla

Showing results (221-230 of 506) with videos related to

Pageof 51
Sort By:
RMD Open|April 26, 2016
Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS CohortGuillermo Carvajal Alegria, Dewi Guellec, Xavier Mariette, et al.
Haematologica|February 8, 2024
Targeting CCR4 with mogamulizumab in refractory CD3<sup>-</sup>CD4<sup>+</sup> lymphocytic-variant hypereosinophilic syndromeEmmanuel Ledoult, Matthieu Groh, Bertrand Meresse, et al.
Journal of Clinical Immunology|July 12, 2011
Active immunological profile is associated with systemic Sjögren's syndromeClothilde Martel, Guillaume Gondran, David Launay, et al.
Rheumatology (Oxford, England)|December 3, 2019
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohortCarina Mihai, Oliver Distler, Ana Maria Gheorghiu, et al.
Respiratory Research|May 25, 2021
Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study)Mouhamad Nasser, Sophie Larrieu, Loic Boussel, et al.
Clinical and Experimental Rheumatology|October 4, 2011
Association study of B-cell marker gene polymorphisms in European Caucasian patients with systemic sclerosisKaren Dawidowicz, Philippe Dieudé, Jérôme Avouac, et al.
American Journal of Hematology|December 17, 2017
Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adultsAlexandra Serris, Zahir Amoura, Florence Canouï-Poitrine, et al.
Autoimmunity Reviews|February 6, 2023
The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohortAmalia Colalillo, Anna-Maria Hoffmann-Vold, Chiara Pellicano, et al.
Healthcare (Basel, Switzerland)|September 9, 2023
Activities of Clinical Expertise and Research in a Rare Disease Referral Centre: A Place for Telemedicine beyond the COVID-19 Pandemic?Quentin Ducrocq, Laurence Guédon-Moreau, David Launay, et al.
Clinical and Experimental Rheumatology|July 8, 2016
A candidate gene study identifies a haplotype of CD2 as novel susceptibility factor for systemic sclerosisEugenie Koumakis, Matthieu Bouaziz, Philippe Dieudé, et al.
Pageof 51

Showing results (221-230 of 506) with videos related to

Sort By:
Pageof 51
RMD Open|April 26, 2016
Epidemiology of neurological manifestations in Sjögren's syndrome: data from the French ASSESS CohortGuillermo Carvajal Alegria, Dewi Guellec, Xavier Mariette, et al.
Haematologica|February 8, 2024
Targeting CCR4 with mogamulizumab in refractory CD3<sup>-</sup>CD4<sup>+</sup> lymphocytic-variant hypereosinophilic syndromeEmmanuel Ledoult, Matthieu Groh, Bertrand Meresse, et al.
Journal of Clinical Immunology|July 12, 2011
Active immunological profile is associated with systemic Sjögren's syndromeClothilde Martel, Guillaume Gondran, David Launay, et al.
Rheumatology (Oxford, England)|December 3, 2019
Incidence and risk factors for gangrene in patients with systemic sclerosis from the EUSTAR cohortCarina Mihai, Oliver Distler, Ana Maria Gheorghiu, et al.
Respiratory Research|May 25, 2021
Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study)Mouhamad Nasser, Sophie Larrieu, Loic Boussel, et al.
Clinical and Experimental Rheumatology|October 4, 2011
Association study of B-cell marker gene polymorphisms in European Caucasian patients with systemic sclerosisKaren Dawidowicz, Philippe Dieudé, Jérôme Avouac, et al.
American Journal of Hematology|December 17, 2017
Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adultsAlexandra Serris, Zahir Amoura, Florence Canouï-Poitrine, et al.
Autoimmunity Reviews|February 6, 2023
The role of TAPSE/sPAP ratio in predicting pulmonary hypertension and mortality in the systemic sclerosis EUSTAR cohortAmalia Colalillo, Anna-Maria Hoffmann-Vold, Chiara Pellicano, et al.
Healthcare (Basel, Switzerland)|September 9, 2023
Activities of Clinical Expertise and Research in a Rare Disease Referral Centre: A Place for Telemedicine beyond the COVID-19 Pandemic?Quentin Ducrocq, Laurence Guédon-Moreau, David Launay, et al.
Clinical and Experimental Rheumatology|July 8, 2016
A candidate gene study identifies a haplotype of CD2 as novel susceptibility factor for systemic sclerosisEugenie Koumakis, Matthieu Bouaziz, Philippe Dieudé, et al.
Pageof 51